Bristol Myers Squibb (BMY) Total Current Liabilities (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Total Current Liabilities data on file, last reported at $19.2 billion in Q1 2026.

• Quarterly Total Current Liabilities fell 20.41% year-over-year to $19.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.2 billion (down 20.41% YoY) and the FY2025 annual result came in at $23.4 billion, down 1.5% from the prior year.
• Total Current Liabilities declined to $19.2 billion in Q1 2026 per BMY's latest filing, from $23.4 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $28.1 billion in Q3 2025 and bottomed at $18.9 billion in Q3 2022.
• The 5-year median for Total Current Liabilities is $22.8 billion (2022), against an average of $22.8 billion.
• The widest annual swing landed in 2024, when Total Current Liabilities jumped 35.3%; it then dropped 20.41% in 2026.
• Tracing BMY's Total Current Liabilities over 5 years: stood at $21.9 billion in 2022, then gained by 1.7% to $22.3 billion in 2023, then increased by 6.79% to $23.8 billion in 2024, then declined by 1.5% to $23.4 billion in 2025, then declined by 18.19% to $19.2 billion in 2026.
• Per Business Quant, the three latest BMY Total Current Liabilities figures stand at $19.2 billion (Q1 2026), $23.4 billion (Q4 2025), and $28.1 billion (Q3 2025).

Peer Comparison